Osteopontin: an essential regulatory protein in idiopathic pulmonary fibrosis
Author:
Funder
Jiangsu Provincial Key Research and Development Program
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,General Medicine,Physiology,Histology
Link
https://link.springer.com/content/pdf/10.1007/s10735-023-10169-y.pdf
Reference117 articles.
1. Abdelaziz Mohamed I, Gadeau AP, Hasan A, Abdulrahman N, Mraiche F (2019) ‘Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis’, Cells, 8
2. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and Disease. J Clin Invest 119:1438–1449
3. Adegunsoye A, Alqalyoobi S, Linderholm A, Bowman WS, Lee CT, Pugashetti JV, Sarma N, Ma SF, Haczku A, Sperling A, Strek ME, Noth I and J. M. Oldham. 2020. ‘Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis’, Chest, 158: 1526–1534
4. Beeh KM, Beier J, Kornmann O, Buhl R (2003) Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and healthy subjects. Respir Med 97:634–639
5. Borensztajn K, Crestani B, Kolb M (2013) Idiopathic Pulmonary Fibrosis: from epithelial injury to biomarkers–insights from the bench side. Respiration 86:441–452
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3